ID Management A/S’s Pfizer PFE Stock Holding History

ID Management A/S’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$9.48M	Buy	283,661 +34,462	+14%	+$1.1M	3%	6
2016 Q1	$7.01M	Hold	249,199	–	–	2.25%	11
2015 Q4	$7.63M	Buy	249,199 +142,967	+135%	+$4.5M	2.46%	8
2015 Q3	$3.17M	Buy	+106,232	New	+$3.41M	1.37%	19

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ID Management A/S's PFE Position: Q2 2016 in Review

ID Management A/S increased its Pfizer (PFE) stake by 14% in Q2 2016, buying an estimated $1.1M and bringing the position to 283,661 shares worth $9.48M. The position accounts for 3% of the portfolio, ranked #6.

ID Management A/S first reported a position in PFE in Q3 2015 and has held it in 4 quarters since. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

ID Management A/S held 283,661 shares of Pfizer worth $9.48M as of Q2 2016.
ID Management A/S bought 34,462 Pfizer shares in Q2 2016, an estimated $1.1M.
Pfizer made up 3% of ID Management A/S's portfolio in Q2 2016, its #6 holding.
ID Management A/S first reported a position in Pfizer in Q3 2015 and has held it in 4 quarters since.
1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on ID Management A/S's 13F filing for Q2 2016, filed 14 Jul 2016.